| Ytd | 90.77% | |
| 1y | 44.21% |
| Open | 12.44 | Prev Close | 12.66 | Low | 12.21 | High | 13.13 | Mkt Cap | 2.11B |
| Vol | 8.38M | Avg Vol | 5.53M | EPS | -1.58 | P/E | N/A | Forward P/E | -78.21 |
| Beta | 2.44 | Short Ratio | 8.08 | Inst. Own | 67.51% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 9.64 | 200-d Avg | 9.04 | 1yr Est | 14.11 |
NVAX News
In the most recent trading session, Novavax (NVAX) closed at $12.82, indicating a +1.26% shift from
MRNA, BNTX and NVAX shares rally after reports of a planned NIH-backed initiative to accelerate pers
Stephen King slammed Trump’s incoming press secretary over her vaccine conspiracy theories and contr
A new NIH-backed initiative to speed up personalized cancer vaccine development sent stocks like MRN
Vaccine and biotechnology names are leading a sharp sector rally, and a small protein-vaccine develo
U.S. stocks rose Friday; Humana jumped 12.3% after improved 2027 Medicare Advantage ratings and reaf
Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is w
Shares of Novavax, Inc. (NASDAQ: NVAX - Get Free Report) were up 10.5% during mid-day trading on Mon
Novavax (NASDAQ:NVAX) reported second-quarter financial results on Thursday. The transcript from the
Novavax is pulling back Tuesday after surging more than 20% Monday. Vaccine stocks rallied on a susp
Vaccine stocks are trending on Tuesday. Shares of Moderna Inc. (NASDAQ:MRNA), Vaxcyte Inc. (NASDA
NVAX, NVDA, MELI, NU, PTC were among the stocks seen trending on Monday, Oct. 5, 2026.
Unconfirmed plague fears sent Novavax up 24% in a potential short squeeze, lifting vaccine stocks de
This whale alert can help traders discover the next big trading opportunities. Whales are entities w